Viewing Study NCT06467513



Ignite Creation Date: 2024-07-17 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06467513
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2024-06-14

Brief Title: To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications
Sponsor: Zhang XIao Mei
Organization: Zunyi Medical College

Study Overview

Official Title: To Investigate the Effect of Esketamine on Hemodynamics and Postoperative Pulmonary Complications in Patients Undergoing Heart Valve Replacement Surgery
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of this study was to evaluate the effect of esketamine on intraoperative hemodynamics in patients with heart valve replacement and to mitigate postoperative pulmonary complications
Detailed Description: After being informed of the study and potential risks all patients who gave written informed consent will undergo pre-operative screening to determine eligibility for study enrollment Before operation eligible patients were randomly divided into esketamine group 02mgkg intraoperative pump esketamine group 04mgkg intraoperative pump and blank control group physiological salt pump in a double-blind way at a ratio of 111

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None